| 查看: 1511 | 回复: 0 | |||
852dd木虫 (正式写手)
|
[交流]
Multiple Postdoc/Visiting Scholar Positions_Rice University
|
|
Postdoc/visiting scholar positions are available in the Chemical Biology Group of Dr. Han Xiao at Rice University (http://xiao.rice.edu). The focus of our research is the development of innovative chemical tools allowing us to understand complex biology system as well as develop novel therapeutic strategies. More information on the research program can be found at: http://xiao.rice.edu We are currently accepting applications for highly self-motivated postdocs with one of the following expertise: Metabolic Engineering: We are looking for postdoc fellows/visiting scholars with experiences in metabolic engineering. Candidates with experiences in genome editing, protein engineering, and/or cell engineering are preferred. Dye Development: We are looking for postdoc fellows/visiting scholars with a strong background in fluorophore Development. Experience in cell imaging is a plus. Targeted therapy: We are looking for postdoc fellows/visiting scholars with a strong background in targeted therapy. Experience in antibody therapy, bispecific antibody therapy, and/or other immunotherapy is a plus. Please send your CV with publication list, and contact information for three references, to han.xiao@rice.edu. In addition, please indicate in the email your research interest, how it fits into the research program, and your expected career path. Rice University is a leading research university in the vibrant urban setting of Houston, TX, the fourth largest city in the U.S. Rice is a small, private university with exceptional strengths in natural science, engineering and biomedicine. Rice University is consistently ranked among the nation’s top 20 universities by U.S. News & World Report. |
回复此楼» 猜你喜欢
只有每年这种时候来逛逛小木虫
已经有26人回复
-
2026国自然函评费到账
已经有10人回复
-
filecode，4个jtjc了
已经有16人回复
-
售一区SCI文章T0P，我:8O.551.O54,科目全,可十急
已经有4人回复
-
人气不行了
已经有8人回复
-
今天基金会出结果吗？20260819
已经有17人回复
-
售SCI一区T0P文章，我:8O.55.1.O.54,科目全,可伽急
已经有9人回复
-
时间戳今天，20号变了
已经有5人回复
-
放榜前的不淡定
已经有14人回复
-
建议基金发布提前给出明确的时间点
已经有13人回复
40